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Abstract. As part of its investigations, the EU-funded ASSESS CT project 
developed an Economic Assessment Model for assessing SNOMED CT’s and 
other terminologies’ socio-economic impact in a systematic approach. 
Methodology and key elements of the model are presented: cost and benefit 
indicators for assessing deployment, and a cost-benefit analysis tool to collect, 
estimate, and evaluate data. 
Keywords. Semantic interoperability, SNOMED CT, costs, benefits 
1. Introduction 
Considerable efforts have been invested into the development of standards for health 
information representation and communication, with an increasing focus on semantic 
interoperability. SNOMED CT (Systematized Nomenclature of Medicine-Clinical 
Terms) is increasingly seen as a unifying ontological standard, with the potential to 
solve many semantic interoperability issues. Yet adoption of SNOMED CT in Europe 
is slow, and only few countries have actual implementation experiences [1-3]. 
Consequently, the evidence is scarce on a) the benefits of SNOMED CT for semantic 
interoperability of eHealth services and b) the challenges associated with the adoption 
of a comprehensive clinical terminology. 
The EU-funded ASSESS CT project investigates the fitness of SNOMED CT as a 
potential standard for EU-wide eHealth deployments. To cover core implementation 
aspects, the project analyzed SNOMED CT’s impact from technical, business, 
organizational, governance and socio-economic viewpoints [4]. This paper presents the 
interim results of the socio-economic analysis of SNOMED CT. The main contribution 
is the development of an Economic Assessment Model that can be used to assess 
SNOMED CT and other terminologies’ socio-economic impact systematically. Such 
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economic assessments are valuable for public authorities when deciding on future 
investment in clinical terminologies, because they allow customization to different 
contexts, and help to forecast the likelihood of a reasonable return on investment. 
2. Method 
for each specific stakeholder are needed. Monetary values have to be assigned for the 
economic performance to be evaluated. This enables, in the aggregate, potential 
common patterns, trends and relationships to be identified. The method that supports 
the linking of these data is cost-benefit analysis (CBA). CBA allows different outcomes 
to be evaluated through common measures, and it can reflect a different allocation of 
resources before and after an investment. A key merit of CBA is that it allows for 
comparative, as well as single-option evaluation over time (e.g. comparing two 
terminologies, or observing the accruing costs and benefits for a specific terminology).  
Costs and benefits are captured in indicators, which are central to the assessment. 
The cost and benefit indicators in Assess CT are measurable outputs comprised of 
variables incorporated into formulae. Combined, these indicators provide the 
socioeconomic data that allow assessing interventions, such as the regional or national 
adoption of SNOMED CT in Europe. The indicator development process is depicted 
below. 
Figure 1. Approach to indicator development in the ASSESS CT project 
2.1. Development of indicator definitions and indicator description 
The following activities allowed us to identify and describe indicators 
• Documentation of methodological challenges in existing studies. Through a 
systematic literature review we got an overview of the scarcely documented 
costs and benefits for clinical terminology implementation, and showed that 
especially existing benefit indicators were often speculative i.e. not based on 
real evidence. 
• Cost indicator development and validation. Existing cost indicators were 
analyzed, and new ones added by the ASSESS CT socio-economic working 
group. The group, which are also the authors of this paper, was 
multidisciplinary with representatives from academia as well as eHealth 
authorities and health insurance and have experience within socio-economic 
analysis of eHealth solutions, and SNOMED CT implementation. The cost 
indicators were evaluated in terms of definition and relevance for national 
semantic interoperability strategies by European eHealth stakeholders at the 
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1stASSESS CT validation workshop both individually using questionnaires 
and through group work and discussions. Data analysis allowed a consolidated 
list of cost indicators to be developed. 
• Benefit indicator development and validation. The socio-economic working 
group analyzed data collected in ASSESS CT through focus groups, 
questionnaires and case studies. We used the analysis of implementation 
experiences to confirm or reject theoretical benefit indicators. In addition, we 
discussed which benefit indicators were most important to stakeholders at the 
2nd ASSESS CT validation workshop, still with focus on real implementation 
experiences. Data analysis allowed a consolidated list of benefit indicators to 
be developed. Contrary to cost indicators, benefits, at this stage of the 
analysis, can only be defined as measurable units in concrete use case or case 
studies. 
2.2. Indicator operationalisation, population with data, and integration into CBA tool 
Operationalization of indicators means that each indicator needs to be made 
quantifiable, and indicator population means finding these quantities. The 
socioeconomic working group established an initial operationalization. To validate the 
operationalization and populate indicators with data, a Danish-Swedish implementation 
cost-benefit study was performed including a dedicated focus group where key 
stakeholders from eHealth authorities and national implementation projects in Denmark 
and Sweden were asked to quantify cost and benefits of their projects, for example 
national translation projects and development of national terminology subsets. 
However, where actual evidence was not available, assumptions needed to be made. 
For the example Skills development and training, appropriate assumptions need to be 
made regarding: the average number of trainers needed; possible sources of 
information are country reports on implementation experience; average number of 
meetings needed. This is highly dependable on the scope of training as well as the 
number of trained staff, their level of understanding, etc.; and how much is lost in € 
when a professional spends time off work to be trained. The indicators were 
implemented in a Microsoft Excel-based CBA tool, based on earlier developments in 
the assessment and evaluation for e-service deployment in health, care and ageing [5]. 
3. Results 
3.1. Indicator definitions and indicator description 
When defining indicators, we aimed for short and precise definitions that are easy to 
understand without additional information. For example, “Legacy costs” carried a wide 
set of meanings, so we chose a more specific definition - “Legacy costs of 
administration”. As an overview, the set of cost indicators developed in the ASSESS 
CT project is presented in Table 1, and the provisional set of major benefit indicators is 
presented in Table 2. Notice that the latter is exclusive to the adoption of SNOMED 
CT. 
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Costs related to organisational infrastructure
C1 License costs 
C2 Decision making costs for adoption of terminologies 
C3 Release management costs 
C4 National Release Centre (NRC) costs 
C5 Legacy costs of administration 
C6 Promoting Implementations 
Costs related to technical infrastructure 
C7 Translation costs 
C8 Mapping costs 
C9 Customisation costs 
C10 Implementation testing costs (user pilots, user interface) 
C11 Integration into software products 
C12 Terminology Binding Costs 
Cost related to capacity-building 
C13 Skills Development and Training costs 
C14 Educational material costs 
Cost related to tools
C15 Terminology management system (TMS) costs 
Table 2. List of benefit indicators for potential large scale clinical terminology implementation 
Nr Benefit indicator 
B1 Terminology across professional boundaries 
B2 Enhancing clinical decision support systems and medication procedures 
B3 Patient-friendly terms for complex medical language 
B4 Capture clinical details and reporting for administration purposes 
B5 Useful analytics for clinical audits, population health management and research 
B6 Interlingua standard supporting vendors and users; Enhancement to vendor systems 
B7 Enabling cross-border interoperability 
B8 Up-to-date terminology supporting open-ended needs 
The description of each indicator includes scope, specificities, and assumptions 
about the size and form of the indicator across the different scenarios. For example, the 
description of the indicator “Skills development and training” is presented in Figure 2. 
Figure 2. Elements of the indicator description 
3.2. Indicator operationalization and indicator population with data 
The data collected from the Danish-Swedish case study meant that for each indicator, 
the appropriate variables and metrics could be identified. In the indicator example 
“Skills development and training” the variables form the following equation: 
Table 1. List of cost indicators for potential large scale clinical terminology implementation 
Nr Cost indicator 
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The assessment framework allowed for cost items (within indicators) to be 
assigned to different stakeholders, as the underlying CBA tool is stakeholder-centric.  
We populated the CBA tool using the data from the Danish-Swedish case study, as 
well as most appropriate assumptions. The indicators were implemented in the 
Microsoft Excel-based CBA tool, to become part of a public project deliverable 
available to the community. Interested parties can use the tool to perform their own 
analyses for a specific case. Comprehensive information based on the indicator 
descriptions, available figures and assumptions are incorporated to guide them through 
the assessment process. 
4. Discussion 
The ASSESS CT project has developed the first draft of an economic assessment 
model to base any impact assessment on scientific methodologies, real observations, 
and actual data. Several methodological challenges exist, e.g. a key step towards 
assessing SNOMED CT is to fill the indicators with real data, i.e. figures and monetary 
values. We based our analysis on the Danish-Swedish case study, but still rely heavily 
on “best guesses”. However, similar projects have also had difficulties finding such 
data. For example, the IHTSDO commissioned report on ‘Building the Business Case 
for SNOMED CT’ offers some extensive analysis of costs and benefits that may arise 
from the adoption of SNOMED CT, but does not provide a single case study or 
example where actual costs or benefits were quantified [6]. The strength of our 
approach is that indicators and assumptions are implemented in a customizable CBA 
tool, which can be refined whenever better data becomes available. The next step is to 
a) finalise the CBA method and b) produce a toolkit for general use by practitioners, 
scientists, and policy-makers alike. 
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